z-logo
open-access-imgOpen Access
Real-world efficacy of nivolumab plus ipilimumab combination therapy versus nivolumab monotherapy for Stage IV melanoma patients in Asia
Author(s) -
Takuya Maeda,
Azusa Hiura,
Jiro Uehara,
Rino Toyoshima,
Tomoe Nakagawa,
Koji Yoshino
Publication year - 2021
Publication title -
european journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.48
H-Index - 71
eISSN - 1952-4013
pISSN - 1167-1122
DOI - 10.1684/ejd.2021.4139
Subject(s) - nivolumab , medicine , ipilimumab , oncology , stage (stratigraphy) , melanoma , combination therapy , dermatology , immunotherapy , cancer , cancer research , paleontology , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom